Literature DB >> 17707887

Validity of Pelvic Pain, Urgency, and Frequency questionnaire in patients with interstitial cystitis/painful bladder syndrome.

M Eric Brewer1, Wesley M White, Frederick A Klein, Leslie M Klein, W Bedford Waters.   

Abstract

OBJECTIVES: To determine the validity of the Pelvic Pain, Urgency, and Frequency (PUF) questionnaire according to its correlation with cystoscopy with hydrodistension (C-HD) findings.
METHODS: A prospective study of new patients with a clinical history consistent with interstitial cystitis/painful bladder syndrome (IC/PBS) was undertaken. All patients underwent history and physical examination, urinalysis, and urine culture and completed a PUF questionnaire before undergoing C-HD. The pertinent data collected included the preoperative PUF scores, bladder capacity, and cystoscopic findings consistent with IC/PBS (petechial hemorrhage and/or terminal hematuria). Statistical analysis was performed.
RESULTS: From June 1, 2005 to December 31, 2005, 97 patients with a new clinical diagnosis of IC/PBS were prospectively evaluated. All patients completed a PUF questionnaire before C-HD. The average PUF score was 21 (range 8 to 35). The mean bladder capacity was 756 mL (range 250 to 1400). The C-HD was positive in 54 (56%) of 97 patients. Of these 54 patients, 27 had a PUF score of less than 20, 22 had a PUF score of 20 to 29, and 5 patients had a PUF score of greater than 30. When evaluated statistically, no correlation was apparent between the PUF questionnaire scores and the cystoscopic findings of IC/PBS (P <0.05).
CONCLUSIONS: As determined by the correlation with the C-HD, the PUF questionnaire appears to be neither a reliable predictor of IC/PBS nor a valuable predictor of disease severity. However, the inherent limitations of C-HD and the lack of a definitive diagnostic instrument for IC/PBS limit any authoritative conclusions. Therefore, the diagnosis of IC/PBS should remain one of exclusion and should depend on a constellation of widely recognized symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 17707887     DOI: 10.1016/j.urology.2007.06.1089

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  13 in total

Review 1.  Pelvic pain in urogynaecology. Part I: evaluation, definitions and diagnoses.

Authors:  Tilemachos Kavvadias; Kaven Baessler; Bernhard Schuessler
Journal:  Int Urogynecol J       Date:  2010-07-20       Impact factor: 2.894

Review 2.  Interstitial cystitis/bladder pain syndrome: diagnosis and management.

Authors:  I Offiah; S B McMahon; B A O'Reilly
Journal:  Int Urogynecol J       Date:  2013-02-22       Impact factor: 2.894

3.  Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens.

Authors:  Anthony T Corcoran; Naoki Yoshimura; Vikas Tyagi; Bruce Jacobs; Wendy Leng; Pradeep Tyagi
Journal:  World J Urol       Date:  2012-03-24       Impact factor: 4.226

4.  Diagnosis of interstitial cystitis/bladder pain syndrome in women with chronic pelvic pain: a prospective observational study.

Authors:  Claudia Cheng; Anna Rosamilia; Martin Healey
Journal:  Int Urogynecol J       Date:  2012-03-08       Impact factor: 2.894

5.  Mirabegron as adjuvant treatment for patients with interstitial cystitis/bladder pain syndrome.

Authors:  Michael Di Lena; Victoria Tolls; Kerri-Lynn Kelly; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

6.  Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective study.

Authors:  Claudio Giberti; Fabrizio Gallo; Pierluigi Cortese; Maurizio Schenone
Journal:  Ther Adv Urol       Date:  2013-08

7.  Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation.

Authors:  Serge P Marinkovic; Lisa M Gillen; Christina M Marinkovic
Journal:  Int Urogynecol J       Date:  2010-09-17       Impact factor: 2.894

8.  Pelvic Floor and Urinary Distress in Women with Fibromyalgia.

Authors:  Kim Dupree Jones; Charlene Maxwell; Scott D Mist; Virginia King; Mary Anna Denman; W Thomas Gregory
Journal:  Pain Manag Nurs       Date:  2015-08-08       Impact factor: 1.929

9.  Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: long-term treatment results.

Authors:  M Cervigni; F Natale; L Nasta; A Mako
Journal:  Int Urogynecol J       Date:  2012-05-09       Impact factor: 2.894

10.  Bladder pain syndrome: validation of simple tests for diagnosis in women with chronic pelvic pain: BRaVADO study protocol.

Authors:  Seema A Tirlapur; Lee Priest; Daniel Wojdyla; Khalid S Khan
Journal:  Reprod Health       Date:  2013-12-04       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.